Get my own profile
Public access
View all9 articles
0 articles
available
not available
Based on funding mandates
Co-authors
- Maurizio Chiriva InternatiAssociate Professor, University of Texas, Mdanderson Cancer CenterVerified email at mdanderson.org
- Everardo CobosUTRGV School of MedicineVerified email at utrgv.edu
- Leonardo MirandolaKiromic Biopharma, Inc.Verified email at kiromic.com
- Fabio GrizziHumanitas Research Hospital, Rozzano, Milan, ItalyVerified email at humanitasresearch.it
- Douglas YeeProfessor of MedicineVerified email at umn.edu
- James G. JacksonTulane School of MedicineVerified email at tulane.edu
- Venu Madhav KonalaGeorgia Cancer Specialists with Northside hospitalVerified email at gacancer.com
- Susan HilsenbeckBaylor College of MedicineVerified email at bcm.edu
- Raffaella ChiaramonteResearcher and Assistant professor of general pathology, University of MilanoVerified email at unimi.it
- Adrian V. LeeProfessor of Pharmacology, University of PittsburghVerified email at pitt.edu
- Jon HerringtonVerified email at exchange.tamu.edu
- Manuel HidalgoWeill Cornell MedicineVerified email at med.cornell.edu
- Michael DeanNational Cancer InstititueVerified email at mail.nih.gov
- Daniel Von HoffChief Scientific Officer US Oncology, Chief Scientific Officer TGen, Distinguished Professor MayoVerified email at tgen.org
- Elisa Lazzari, PhDCenter for Discover and Innovation Hackensack University Medical CenterVerified email at hackensackmeridian.org
Follow
Jose A. Figueroa, MD
Founder Kiromic, Inc, Houston Texas, Senior Medical Oncologist at Oncolgy Consultants
Verified email at kiromic.com